{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:59:43Z","timestamp":1789516783042,"version":"build-2803163510"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>This longitudinal observational study evaluated changes in depressive symptoms associated with ritualistic ayahuasca use in patients diagnosed with depressive disorders, as well as depressive burden in individuals with anxiety and substance use disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The research was conducted with 280 adults treated at clinics in the northwestern region of the state of S\u00e3o Paulo, under the jurisdiction of Regional Health Division XV (DRS XV), which covers a population of over 2 million inhabitants. Participants were assessed at six different time points over a six-month follow-up period after the ayahuasca intervention, with depressive symptoms measured using the Montgomery\u2013\u00c5sberg Depression Rating Scale (MADRS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The results indicate a significant reduction in depression scores shortly after the intervention, with improvements sustained for up to 180 days, though individual responses varied. The analysis reveals that ayahuasca, when combined with psychotherapeutic support, can provide significant benefits in reducing symptoms of depression and anxiety, and also shows potential in the treatment of substance dependence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We concluded that the final variability in responses suggests that psychodynamic and clinical factors, such as the integration of the psychedelic experience and therapeutic support, play a crucial role in treatment effectiveness. This study contributes to the consolidation of psychedelic-assisted therapeutic protocols, highlighting the importance of continuous and personalized follow-up in the treatment of complex psychiatric conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2026.1726909","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T05:23:14Z","timestamp":1769664194000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["The therapeutic potential of ayahuasca in depression, generalized anxiety, and substance use disorders: modulation of the depressive burden in a longitudinal study"],"prefix":"10.3389","volume":"17","author":[{"given":"Gl\u00e1ucio Silva","family":"Camargos","sequence":"first","affiliation":[{"name":"\u00b9 Department of Neurological Sciences, Psychiatry and Medical Psychology, Faculty of Medicine of S\u00e3o Jos\u00e9 do Rio Preto (FAMERP)","place":["S\u00e3o Jos\u00e9 do Rio Preto, S\u00e3o Paulo, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldo Magela","family":"de Faria J\u00fanior","sequence":"additional","affiliation":[{"name":"Faculty of Medicine of S\u00e3o Jos\u00e9 do Rio Preto (FAMERP)","place":["S\u00e3o Jos\u00e9 do Rio Preto, S\u00e3o Paulo, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Louren\u00e7o","sequence":"additional","affiliation":[{"name":"UNI Shamanic Institute of S\u00e3o Jos\u00e9 do Rio Preto (IXUNI)","place":["S\u00e3o Jos\u00e9 do Rio Preto, S\u00e3o Paulo, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo Maria","family":"de Ara\u00fajo Filho","sequence":"additional","affiliation":[{"name":"\u00b9 Department of Neurological Sciences, Psychiatry and Medical Psychology, Faculty of Medicine of S\u00e3o Jos\u00e9 do Rio Preto (FAMERP)","place":["S\u00e3o Jos\u00e9 do Rio Preto, S\u00e3o Paulo, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/7854_2021_277","article-title":"Ayahuasca for the treatment of depression","volume":"56","author":"Palhano-Fontes","year":"2022","journal-title":"Curr Topics Behav Neurosci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X16666180125095902","article-title":"Ayahuasca: Psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness","volume":"17","author":"Hamill","year":"2019","journal-title":"Curr Neuropharmacology"},{"key":"B3","volume-title":"Ayahuasca: Botanical illustration of","author":"England","year":"2021"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000001725","article-title":"Psychedelic therapy: A primer for primary care clinicians\u2014N,N-Dimethyltryptamine and ayahuasca","volume":"31","author":"Shinozuka","year":"2024","journal-title":"Am J Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1089\/psymed.2024.0002","article-title":"The antidepressant effects of vaporized N,N-dimethyltryptamine: An open-label pilot trial in treatment-resistant depression","volume":"3","author":"Falchi-Carvalho","year":"2025","journal-title":"Psychedelic Med (New Rochelle)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.euroneuro.2022.10.008","article-title":"Ayahuasca\u2019s therapeutic potential: What we know\u2014and what not","volume":"66","author":"Maia","year":"2023","journal-title":"Eur Neuropsychopharmacol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-019-05445-3","article-title":"Ayahuasca\u2019s \u2018afterglow\u2019: Improved mindfulness and cognitive flexibility in ayahuasca drinkers","volume":"237","author":"Murphy-Beiner","year":"2020","journal-title":"Psychopharmacol (Berlin)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291718001356","article-title":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: A randomized placebo-controlled trial","volume":"49","author":"Palhano-Fontes","year":"2019","journal-title":"psychol Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/0269881120936486","article-title":"Changes in inflammatory biomarkers are related to the antidepressant effects of ayahuasca","volume":"34","author":"Galv\u00e3o-Coelho","year":"2020","journal-title":"J Psychopharmacol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/JCP.0000000000000436","article-title":"Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: A SPECT study","volume":"36","author":"Sanches","year":"2016","journal-title":"J Clin Psychopharmacol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2728","article-title":"How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy","volume":"35","author":"Orsolini","year":"2020","journal-title":"Hum Psychopharmacology: Clin Exp"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1017\/S109285292400213X","article-title":"Ayahuasca: Pharmacology, safety, and therapeutic effects","volume":"30","author":"Dos Santos","year":"2024","journal-title":"CNS Spectrums"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ph16060831","article-title":"Infoveillance and critical analysis of the systematically reviewed literature on dimethyltryptamine and the \u201cGod molecule","volume":"16","author":"Al-Imam","year":"2023","journal-title":"Pharmaceuticals"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2007.03.014","article-title":"Effect of comorbid anxiety on treatment response in bipolar depression","volume":"104","author":"Tohen","year":"2007","journal-title":"J Affect Disord"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/acer.13400","article-title":"The validity of the Montgomery- \u00c5sberg depression rating scale in an inpatient sample with alcohol dependence","volume":"41","author":"Hobden","year":"2017","journal-title":"Alcohol Clin Exp Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e328303ac5f","article-title":"Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder","volume":"23","author":"Zimmerman","year":"2008","journal-title":"Int Clin Psychopharmacol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-007-0771-x","article-title":"Qualitative changes in symptomatology as an effect of treatment with escitalopram in generalized anxiety disorder and major depressive disorder","volume":"18","author":"Lecrubier","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.879221","article-title":"Psychotherapeutic and neurobiological processes associated with ayahuasca: A proposed model and implications for therapeutic use","volume":"16","author":"Perkins","year":"2023","journal-title":"Front Neurosci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.psc.2023.02.004","article-title":"Role of psychedelics in treatment-resistant depression","volume":"46","author":"Kamal","year":"2023","journal-title":"Psychiatr Clinics North America"},{"key":"B20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-981-97-4402-2_3","article-title":"Efficacy, safety, and tolerability of psychedelics in treatment-resistant depression (TRD)","volume":"1456","author":"Olivier","year":"2024","journal-title":"Adv Exp Med Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2023.2281582","article-title":"Psychedelics for treatment resistant depression: Are they game changers","volume":"24","author":"Kalfas","year":"2023","journal-title":"Expert Opin Pharmacotherapy"},{"key":"B22","doi-asserted-by":"publisher","first-page":"19635","DOI":"10.1038\/s41598-023-44193-5","article-title":"A quantitative textual analysis of the subjective effects of ayahuasca in na\u00efve users with and without depression","volume":"13","author":"Cruz","year":"2023","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jad.2019.07.076","article-title":"Classical psychedelics for the treatment of depression and anxiety: A systematic review","volume":"258","author":"Muttoni","year":"2019","journal-title":"J Affect Disord"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1055\/a-1341-1907","article-title":"Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders","volume":"54","author":"Mertens","year":"2021","journal-title":"Pharmacopsychiatry"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108629","article-title":"Ayahuasca-assisted therapy for substance use disorders","volume":"221","author":"Paquette","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"B26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1177\/02698811231196877","article-title":"Psychological and physiological effects of extended DMT","volume":"38","author":"Luan","year":"2024","journal-title":"J Psychopharmacol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0000438","article-title":"Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey","volume":"2","author":"Bouso","year":"2022","journal-title":"PloS Global Public Health"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.884703","article-title":"Changes in mental health, wellbeing and personality following ayahuasca consumption: Results of a naturalistic longitudinal study","volume":"13","author":"Perkins","year":"2022","journal-title":"Front Pharmacol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02791072.2025.2465800","article-title":"Long-term mental health and wellbeing outcomes associated with naturalistic ayahuasca consumption","author":"Pagni","year":"2025","journal-title":"J Psychoactive Drugs"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.55574","article-title":"The effects of ayahuasca on psychological disorders: A systematic literature review","volume":"16","author":"Sheth","year":"2024","journal-title":"Cureus"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.721537","article-title":"Persisting effects of ayahuasca on empathy, creative thinking, decentering, personality, and well- being","volume":"12","author":"Kiraga","year":"2021","journal-title":"Front Pharmacol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(21)00076-4","article-title":"The therapeutic potential of psychedelics in psychiatric treatment","volume":"8","author":"Carhart-Harris","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/psychoactives2020014","article-title":"Life after Ayahuasca: A Qualitative Analysis of the Psychedelic Integration Experiences of 1630 Ayahuasca Drinkers from a Global Survey","author":"Cowley-Court","year":"2023","journal-title":"Psychoactives"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-018-4988-3","article-title":"Sub- acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution","volume":"235","author":"Uthaug","year":"2018","journal-title":"Psychopharmacol (Berlin)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2021.102206","article-title":"Ayahuasca and the traveller: A scoping review of risks and possible benefits","volume":"44","author":"Houle","year":"2021","journal-title":"Travel Med Infect Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1162\/jocn_a_02003","article-title":"Altered state of consciousness and mental imagery as a function of N,N-dimethyltryptamine concentration in ritualistic ayahuasca users","volume":"35","author":"Ramaekers","year":"2023","journal-title":"J Cogn Neurosci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1177\/02698811241301216","article-title":"Ayahuasca enhances the formation of hippocampal-dependent episodic memory without impacting false memory susceptibility in experienced ayahuasca users: An observational study","volume":"39","author":"Doss","year":"2025","journal-title":"J Psychopharmacol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"New Engl J Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1002\/pcn5.146","article-title":"Ayahuasca: A review of historical, pharmacological, and therapeutic aspects","volume":"2","author":"Ruffell","year":"2023","journal-title":"PCN Rep"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-018-5085-3","article-title":"Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits","volume":"236","author":"Dom\u00ednguez-Clav\u00e9","year":"2019","journal-title":"Psychopharmacol (Berlin)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1302559","article-title":"Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: A controlled trial in healthy subjects","volume":"14","author":"Aicher","year":"2024","journal-title":"Front Psychiatry"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001343","article-title":"Acute psychological adverse reactions in first-time ritual ayahuasca users: A prospective case series","volume":"41","author":"G\u00f3mez-Sousa","year":"2021","journal-title":"J Clin Psychopharmacol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1038\/s41598-020-61169-x","article-title":"Effects of ayahuasca on mental health and quality of life in na\u00efve users: A longitudinal and cross-sectional study combination","volume":"10","author":"Jim\u00e9nez-Garrido","year":"2020","journal-title":"Sci Rep"},{"key":"B44","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1021\/acsptsci.5c00005","article-title":"Psychedelics and the autonomic nervous system: A perspective on their interplay and therapeutic potential","volume":"8","author":"Li","year":"2025","journal-title":"ACS Pharmacol Trans Sci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015383.pub2","article-title":"Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life- threatening diseases","volume":"9","author":"Schipper","year":"2024","journal-title":"Cochrane Database Systematic Rev"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol32070380","article-title":"Psychedelic-assisted therapies for psychosocial symptoms in cancer: A systematic review and meta-analysis","volume":"32","author":"Schuman","year":"2025","journal-title":"Curr Oncol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00213-021-06027-y","article-title":"Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: A systematic review","volume":"239","author":"Schimmers","year":"2022","journal-title":"Psychopharmacol (Berlin)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.9305","article-title":"Psychedelic-assisted therapy for palliative care within a home treatment setting: A case report","volume":"12","author":"Federico","year":"2024","journal-title":"Clin Case Rep"},{"key":"B49","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1556\/2006.2024.00004","article-title":"Psychedelic-assisted therapy for people with gambling disorder","volume":"13","author":"Romero","year":"2024","journal-title":"J Behav Addict"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.euroneuro.2023.05.008","article-title":"Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms","volume":"75","author":"Calder","year":"2023","journal-title":"Eur Neuropsychopharmacol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-024-01817-9","article-title":"Long-term ayahuasca use is associated with preserved global cognitive function and improved memory: A cross-sectional study with ritual users","volume":"275","author":"Fonseca","year":"2025","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1080\/03080188.2022.2075201","article-title":"\u2018Everybody\u2019s creating it along the way\u2019: Ethical tensions among globalized ayahuasca shamanisms and therapeutic integration practices","volume":"48","author":"Marcus","year":"2023","journal-title":"Interdiscip Sci Rev"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1055\/a-1675-3840","article-title":"Beyond the psychoactive effects of ayahuasca: Cultural and pharmacological relevance of its emetic and purging properties","volume":"88","author":"Politi","year":"2022","journal-title":"Planta Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114910","article-title":"Teacher plants\u2014Indigenous Peruvian-Amazonian dietary practices as a method for using psychoactives","volume":"286","author":"Berlowitz","year":"2022","journal-title":"J Ethnopharmacology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104596","article-title":"Psychoanalysis and psychedelics: The censored story in Argentina","volume":"133","author":"Olivieri","year":"2024","journal-title":"Int J Drug Policy"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e2835","DOI":"10.1002\/hup.2835","article-title":"N,N- dimethyltryptamine and Amazonian ayahuasca plant medicine","volume":"37","author":"James","year":"2022","journal-title":"Hum Psychopharmacol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2024.115886","article-title":"Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis","volume":"335","author":"Yao","year":"2024","journal-title":"Psychiatry Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s00115-024-01727-0","article-title":"Psychedelika und Dissoziativa in der Psychiatrie: Herausforderungen in der Behandlung [Psychedelic and dissociative agents in psychiatry: challenges in the treatment","volume":"95","author":"Jungwirth","year":"2024","journal-title":"Nervenarzt"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.15544","article-title":"Psychedelic-inspired approaches for treating neurodegenerative disorders","volume":"162","author":"Saeger","year":"2022","journal-title":"J Neurochemistry"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.1c00812","article-title":"Biochemical mechanisms underlying psychedelic- induced neuroplasticity","volume":"61","author":"Olson","year":"2022","journal-title":"Biochemistry"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.1033816","article-title":"Moderators of Ayahuasca\u2019s biological antidepressant action","volume":"13","author":"de Sousa","year":"2022","journal-title":"Front Psychiatry"},{"key":"B62","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1176\/appi.ajp.2019.19010035","article-title":"Psychedelics and psychedelic-assisted psychotherapy","volume":"177","author":"Reiff","year":"2020","journal-title":"Am J Psychiatry"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1726909\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:15:27Z","timestamp":1771924527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1726909\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":62,"alternative-id":["10.3389\/fpsyt.2026.1726909"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1726909","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"article-number":"1726909"}}